{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:33:17Z","timestamp":1787823197880,"version":"build-2784847793"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p>We measured the circulating levels of interleukin (IL)\u20106 in adult T\u2010cell leukaemia\/lymphoma (ATL) patients using an enzyme\u2010linked immunosorbent assay. The IL\u20106 levels in 59 ATL patients (median 8.2\u2003pg\/ml; range &lt;\u20031.0 to 185.7\u2003pg\/ml) were significantly higher than in 30 healthy controls (median &lt;\u20031.0\u2003pg\/ml; range &lt;\u20031.0 to 3.5\u2003pg\/ml) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) or 32 human T\u2010lymphotropic virus type\u2010I (HTLV\u2010I) carriers (median 4.2\u2003pg\/ml; range \u2003&lt;\u20031.0 to 13.3\u2003pg\/ml) (<jats:italic>P<\/jats:italic>\u2003=\u20030.002). Among the ATL patients, the IL\u20106 levels in the acute\u2010 or lymphoma\u2010type patients were significantly higher than those in the chronic\u2010type patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). The IL\u20106 levels were also higher in the patients with B symptoms than in those without B symptoms (<jats:italic>P<\/jats:italic>\u2003=\u20030.039), and were significantly correlated with increased serum lactate dehydrogenase (LDH) (<jats:italic>P<\/jats:italic>\u2003=\u20030.0004) and C\u2010reactive protein (CRP) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) and decreased serum albumin (<jats:italic>P<\/jats:italic>\u2003=\u20030.0003) values. The patients with elevated IL\u20106 levels had inferior overall survival periods compared to those with normal IL\u20106 levels (<jats:italic>P<\/jats:italic>\u2003=\u20030.025). ATL is a single disease entity, although its clinical features are quite diverse; the increased production of cytokines may cause the diversity of clinical features. The results of our study indicate that IL\u20106 is one such cytokine.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00538.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:57:57Z","timestamp":1047362277000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Circulating interleukin\u20106 levels are elevated in adult T\u2010cell leukaemia\/lymphoma patients and correlate with adverse clinical features and survival"],"prefix":"10.1111","volume":"100","author":[{"given":"Masaomi","family":"Yamamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburou","family":"Momita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.8.1602.1602"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.3.733.733"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90069-A"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120517"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.5.1704.1704"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2650621"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6476"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.1.1.1"},{"key":"e_1_2_6_11_2","first-page":"2118","article-title":"Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms","volume":"53","author":"Kurzrock R.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.2904.2904"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.410"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.575"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.146.2.550","article-title":"IL\u20106 production by human T lymphocytes expression in HTLV\u2010I\u2010infected but not in normal T cells","volume":"146","author":"Villiger P.M.","year":"1991","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.333"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.3.759"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.499"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(90)90028-O"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V61.1.192.192","article-title":"Phenotypic and functional analysis of leukemic cells from 16 patients with adult T\u2010cell leukemia\/lymphoma","volume":"61","author":"Yamada Y.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07718.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609093442"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049662"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1182\/blood.V84.5.1573.1573","article-title":"Transactivation of the human interleukin\u20106 gene by human T\u2010lymphotropic virus type 1 tax protein","volume":"84","author":"Yamashita I.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199209053611"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.8.2534"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00538.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00538.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2141.1998.00538.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00538.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:34:31Z","timestamp":1694414071000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00538.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00538.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00538.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}